ENS-002 (Fermata Derm)

About Concerto Biosciences

Concerto Biosciences is a Cambridge, MA-based biotech pioneering a data-driven approach to microbial ecology. The company's core asset is its integrated platform combining the kChip, which experimentally generates vast datasets on microbial interactions, and the kAI model, which learns from this data to predict behavior and identify synergistic microbial combinations. This platform is being applied to develop a pipeline of microbial-based products, including candidates for atopic dermatitis and vaginal yeast infections, and to form discovery partnerships with industry leaders like Sacco System. Concerto aims to catalyze a third wave of microbial technologies by translating ecological insights into real-world efficacy.

Therapeutic Areas

Other Atopic Dermatitis Drugs